After HSCT, the 3-year RFS of SET-NUP214+ T-ALL and SET-NUP214− T-ALL was 38.5% and 66.4%, respectively(P=0.028), and the difference was statistically significant. Here, NUP214 is linked to acute lymphoblastic leukemia.